ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2854

Majeed Syndrome Causing LPIN2 mutations May Prevent Bone “Healing” By Rendering M2 Macrophage Proinflammatory

Farzana Bhuyan1, Adriana Almeida de Jesus1, Rachel VanTries1, Ronit Herzog2, Karen Onel3, Bernadette Marrero1, Yan Huang1, Katherine R. Calvo4, Gina A. Montealegre Sanchez1, Polly Ferguson5 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Disease Section (TADS), Laboratory of Clinical Investigation and Microbiology (LCIM), NIAID/NIH, Bethesda, MD, 2NYU Langone Medical Center, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD, 5Pediatrics, University of Iowa, Iowa City, IA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Autoinflammation, bone disease, innate immunity, macrophages and osteomyelitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T105 ACR Abstract: Innate Immunity (2850–2855)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: To study the mechanism that leads to bone inflammation in a 4-year old patient of mixed Puerto Rican and African-American background who presented with sterile osteomyelitis (Majeed syndrome), that is caused by two novel compound heterozygous LPIN2 mutations.

Methods: Targeted genetic analysis for known autoinflammatory genes was performed that revealed Majeed syndrome and functional studies (stimulation assays and immune-histochemistry) on patient’s monocytes, monocyte-derived M1 (MDM1) and M2 (MDM2) macrophages (culture with GM-CSF or M-CSF respectively for 5 days) from the Majeed patient, patients with NOMID (n=3) and DIRA (n=4), and healthy controls (n=4) were conducted to assess IL-1 production and the production of other inflammatory cytokines and chemokines.

Results: The patient has a novel splice site mutation on one allele of LPIN2, that leads to a loss of exon 10 and 11, and a novel 16.0 Kb deletion on the other allele deleting exons 7-18 including a conserved residue that confers phosphatase activity. Treatment with IL-1 blocking treatment led to complete clinical remission. Functional studies from monocytes and MDM1 macrophages show increased LSP+ATP induced IL-1 production and increased upregulation of gasdermin D with increased cell death in MDM1s from the Majeed pt. similar to NOMID patients but higher than controls. In contrast, the Majeed pt’s MDM2 produced lower amounts of IL-10 than MDM2 from HC, NOMID and DIRA patients. However, unstimulated Majeed pt’s MDM2 spontaneously produced high levels of IL-8 and CCL2/MCP1 and LPS and ATP stimulated MDM2 macrophages from the Majeed pt. produced significantly higher levels of IL-6, TNF, IL-8 and other chemokines compared to MDM2s from healthy controls and NOMID patients. MDM2 from DIRA patients were more inflammatory than NOMID and HC but less than the Majeed pt’s MDM2s. Studies evaluating the effect of the LPIN2 mutations on osteoclast function are ongoing.

Conclusion: We report two novel loss-of-function mutations in LPIN2, in an American pt. of mixed racial background. The increase in caspase-1 activity and gasdermin D levels in the Majeed pt. are consistent with increased inflammasome activation in monocytes and MDM1s. However, the differentiation of Majeed monocytes into inflammatory MDM2 macrophages that express high levels of TNF, IL-6, IL-8 and chemokines known to activate osteoclasts distinguish the Majeed syndrome pt. from pts with GOF mutations in NLRP3 (causing cryopyrinopthies) and suggest a possible mechanism of sterile osteomyelitis by causing an inflammatory local bone environment that may prevent bone healing.

Acknowledgements: This work was supported by the NIH IRP of NIAID


Disclosure: F. Bhuyan, None; A. Almeida de Jesus, None; R. VanTries, None; R. Herzog, None; K. Onel, None; B. Marrero, None; Y. Huang, None; K. R. Calvo, None; G. A. Montealegre Sanchez, None; P. Ferguson, None; R. Goldbach-Mansky, None.

To cite this abstract in AMA style:

Bhuyan F, Almeida de Jesus A, VanTries R, Herzog R, Onel K, Marrero B, Huang Y, R. Calvo K, Montealegre Sanchez GA, Ferguson P, Goldbach-Mansky R. Majeed Syndrome Causing LPIN2 mutations May Prevent Bone “Healing” By Rendering M2 Macrophage Proinflammatory [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/majeed-syndrome-causing-lpin2-mutations-may-prevent-bone-healing-by-rendering-m2-macrophage-proinflammatory/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/majeed-syndrome-causing-lpin2-mutations-may-prevent-bone-healing-by-rendering-m2-macrophage-proinflammatory/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology